Acute carbamoylated erythropoietin reduces social stress-induced anxiety and depression-related behaviors

The hormone and trophic factor Erythropoietin (EPo) promotes red blood cell production and has neurotrophic effects, modulating behavior and promoting neural plasticity, like neurogenesis. Modifying EPo by attaching a carbamoyl group (cEPo) results in similar neuronal effects without erythropoietic actions. We hypothesize that neuroplastic and learning effects of cEPo may be dependent on its action in dorsal dentate gyrus of the hippocampus, where neurogenesis occurs. The Stress Alternatives Model (SAM) is a 4-day social stress and decision-making paradigm with a large novel aggressor that provides opportunities to avoid interaction via escape routes. Early, male test mice display stable Escape (avoiding aggression) or Stay (acquiescence to aggressor) behavioral phenotypes. In these studies, mice were given a single intracerebroventricular (icv; 100 ng), or single intra-dentate gyrus (iDG; 10 ng) injection of cEPo or vehicle. By Day 4, 30% of icv cEPo treated mice and 37.5% of iDG cEPo treated mice reversed their phenotype (Stay to Escape). Mice receiving vehicle injections did not change. Normalization of social preference, and reduction in fear freezing behavior, after cEPo treatment, coincide with transcriptional changes of orexin receptors (Hcrtr<sub>1</sub> & Hcrtr<sub>2</sub>) in the hippocampus, including phenotype- and treatment-dependent alterations in learning-associated molecular signaling molecules. Hippocampal Hcrtr<sub>1</sub> moderately colocalize with EPo receptors (Epor) in the dentate gyrus, while Hcrtr<sub>2</sub> is expressed with Epor in CA<sub>1</sub>. Anxiolytic actions of cEPo during social interaction indicate mechanisms that influence learning in stressful situations, suggesting that cEPo may be a novel agent for treatment of comorbid conditions related to anxiety, depression, and PTSD.

Authors

Institutions

Publication Details

Journal
Neuropharmacology
Published
2025-06-11
DOI
https://doi.org/10.1016/j.neuropharm.2025.110558
Citations
1
Primary Topic
Erythropoietin and Anemia Treatment
Type
article
Field-Weighted Citation Impact
1.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Acute carbamoylated erythropoietin reduces social stress-induced anxiety and depression-related behaviors

Cliff H. Summers, Monica Sathyanesan, Jazmine D. W. Yaeger, Samuel S. Newton et al.
1 citations
Neuropharmacology
Erythropoietin and Anemia Treatment
1.77
article

Acute carbamoylated erythropoietin reduces social stress-induced anxiety and depression-related behaviors

Cliff H. Summers, Monica Sathyanesan, Jazmine D. W. Yaeger, Samuel S. Newton, Kevin T. Krupp, Clarissa D. Booth, N. Jones, Leighton J. Ledesma, Molykutty John, Aisel Valiño, Nathan Popp
article en
1 citations

Abstract

The hormone and trophic factor Erythropoietin (EPo) promotes red blood cell production and has neurotrophic effects, modulating behavior and promoting neural plasticity, like neurogenesis. Modifying EPo by attaching a carbamoyl group (cEPo) results in similar neuronal effects without erythropoietic actions. We hypothesize that neuroplastic and learning effects of cEPo may be dependent on its action in dorsal dentate gyrus of the hippocampus, where neurogenesis occurs. The Stress Alternatives Model (SAM) is a 4-day social stress and decision-making paradigm with a large novel aggressor that provides opportunities to avoid interaction via escape routes. Early, male test mice display stable Escape (avoiding aggression) or Stay (acquiescence to aggressor) behavioral phenotypes. In these studies, mice were given a single intracerebroventricular (icv; 100 ng), or single intra-dentate gyrus (iDG; 10 ng) injection of cEPo or vehicle. By Day 4, 30% of icv cEPo treated mice and 37.5% of iDG cEPo treated mice reversed their phenotype (Stay to Escape). Mice receiving vehicle injections did not change. Normalization of social preference, and reduction in fear freezing behavior, after cEPo treatment, coincide with transcriptional changes of orexin receptors (Hcrtr<sub>1</sub> & Hcrtr<sub>2</sub>) in the hippocampus, including phenotype- and treatment-dependent alterations in learning-associated molecular signaling molecules. Hippocampal Hcrtr<sub>1</sub> moderately colocalize with EPo receptors (Epor) in the dentate gyrus, while Hcrtr<sub>2</sub> is expressed with Epor in CA<sub>1</sub>. Anxiolytic actions of cEPo during social interaction indicate mechanisms that influence learning in stressful situations, suggesting that cEPo may be a novel agent for treatment of comorbid conditions related to anxiety, depression, and PTSD.

NeuropharmacologyVol. 278
Mayo Clinic (US), University of South Dakota (US), Medical College of Wisconsin (US), Sanford Research (US), Sioux Falls VA Health Care System (US)
Openalex Percentile: Top 15%
Erythropoietin and Anemia Treatment
1.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.